Viewing Study NCT07348861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-30 @ 8:50 PM
Study NCT ID: NCT07348861
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-16
First Post: 2026-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer
Sponsor: Zheng Min
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced cervical cancer View
None cervical cancer stage IB3 (FIGO2018) View
None cervical cancer stage IIA2 (FIGO2018) View
None tumor size ≥ 4 cm cervical cancer stage IIIc1r (FIGO2018) View